Comparative Pharmacology
Head-to-head clinical analysis: ASCOR versus HEXA BETALIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ASCOR versus HEXA BETALIN.
ASCOR vs HEXA-BETALIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ascorbic acid (vitamin C) acts as an antioxidant and a cofactor for several enzymes involved in collagen synthesis, carnitine biosynthesis, and neurotransmitter synthesis. It facilitates iron absorption from the gastrointestinal tract and participates in immune function.
Hexa-Betalin is a combination of six B vitamins (B1, B2, B3, B5, B6, B12) that act as cofactors in various enzymatic reactions involved in energy metabolism, neurotransmitter synthesis, and nerve function.
1 tablet (75 mg) orally once daily for antiplatelet effect; for acute coronary syndrome: initial dose 300 mg orally, then 75 mg orally once daily.
Dosage forms: Tablet 10mg, 50mg, 100mg, 250mg; Injection 50mg/mL. Usual adult dose: 100–250mg orally 1–3 times daily. Maximum 1000mg/day. IV/IM: 50–250mg every 6–8 hours as needed.
None Documented
None Documented
Clinical Note
moderateAscorbic acid + Cyclosporine
"The serum concentration of Cyclosporine can be decreased when it is combined with Ascorbic acid."
Clinical Note
moderateAscorbic acid + Bortezomib
"The therapeutic efficacy of Bortezomib can be decreased when used in combination with Ascorbic acid."
Clinical Note
moderateAscorbic acid + Benzphetamine
"The serum concentration of Benzphetamine can be decreased when it is combined with Ascorbic acid."
Clinical Note
moderateAscorbic acid + Amphetamine
Terminal elimination half-life is 8-12 hours in patients with normal renal function; prolonged to 24-48 hours in renal impairment, requiring dose adjustment.
Terminal elimination half-life is approximately 3-5 hours in patients with normal renal function. This short half-life necessitates frequent dosing for sustained therapeutic effect. Half-life is prolonged in renal impairment.
Renal: 70-90% (as unchanged drug and metabolites), biliary/fecal: minor (<10%)
Renal excretion of unchanged drug accounts for 75-85% of the administered dose. Biliary/fecal elimination is minimal, less than 5%.
Category C
Category C
Vitamin
Vitamin
"The serum concentration of Amphetamine can be decreased when it is combined with Ascorbic acid."